Sign In
Buy AMED
$100.99
+0 (+0%)
At Close: Nov 13, 2025
Amedisys agrees to UnitedHealth buyout offer, scraps Option Care deal
09:10am, Monday, 26'th Jun 2023
Amedisys Inc on Monday agreed to acquired by UnitedHealth Group for $101 per share in cash, and terminated an all-stock deal to be bought by Option Care Health Inc.
Amedisys agrees to merge with UnitedHealth, and terminates deal with Option Care Health
09:09am, Monday, 26'th Jun 2023
Amedisys Inc. AMED, -0.15% disclosed Monday that it has agreed to merge with UnitedHealth Group Inc. UNH, -0.43%, and terminated its merger with Option Care Health Inc. OPCH, +1.47% agreed on in early
4 Stocks to Hold in a Challenging Outpatient Home Health Industry
10:57am, Wednesday, 14'th Jun 2023
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, CHE, AMED and ADUS are well poised
Amedisys: Even Without A Bidding War, The Company Appears Undervalued
01:03am, Friday, 09'th Jun 2023
Amedisys is a leading healthcare services company dedicated to providing clinically excellent care and support at home. Currently reporting FCF generation and proposing workforce optimization, clinica
Strength Seen in Amedisys (AMED): Can Its 15.4% Jump Turn into More Strength?
09:44am, Tuesday, 06'th Jun 2023
Amedisys (AMED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why Shares of Amedisys Are Jumping Monday
11:40am, Monday, 05'th Jun 2023
Optum's new buyout offer is competing with another buyout offer from Option Care Health. This latest offer would be a $3.26 billion all-cash deal.
Amedisys rallies on $3.26B unsolicited bid from UnitedHealth's Optum
11:11am, Monday, 05'th Jun 2023
Amedisys Inc told investors it received an unsolicited $100 per share bid from UnitedHealth Group's Optum unit that may be ‘superior' to a planned merger with Option Care Health, sending its share
Amedisys received unsolicited buyout bid from Optum that could be ‘superior' to deal with Option Care Health
08:39am, Monday, 05'th Jun 2023
Amedisys Inc. AMED, +3.64% disclosed Monday that it had received an unsolicited cash buyout bid for $100 a share from Optum, which the at-home healthcare services company believes could be considered
Amedisys gets over $3 billion unsolicited offer from UnitedHealth's Optum
08:25am, Monday, 05'th Jun 2023
Amedisys Inc said on Monday it had received an unsolicited proposal from UnitedHealth Group's health services company Optum to acquire all of its outstanding shares in an all-cash transaction worth $3
Amedisys (AMED) Q1 Earnings Beat Estimates, Margins Dip
02:26pm, Thursday, 04'th May 2023
Amedisys (AMED) sees a year-over-year decline in the Hospice segment's revenues.
Amedisys (AMED) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
10:47pm, Wednesday, 03'rd May 2023
While the top- and bottom-line numbers for Amedisys (AMED) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare
Amedisys (AMED) New Buyouts Aid Growth, CMS Ruling Unfavorable
12:09pm, Friday, 14'th Apr 2023
For Amedisys (AMED), dealing with the continuous shortage of clinical labo, in nursing in particular, has been challenging.
Here's Why You Should Retain Amedisys (AMED) Stock for Now
09:55am, Tuesday, 04'th Apr 2023
Amedisys's (AMED) share price is likely to grow following an impressive fourth-quarter 2022 performance and new partnerships.
Amedisys to Present at Multiple Healthcare Conferences in March
07:30am, Thursday, 09'th Mar 2023
BATON ROUGE, La., March 09, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul Kusserow,
Amedisys (AMED) Q4 Earnings Beat, Operating Margin Dips
09:47am, Friday, 17'th Feb 2023
Amedisys (AMED) delivers strong Home Health performance in the fourth quarter amid cost pressure.
